Warning: Undefined array key "HTTP_ACCEPT_LANGUAGE" in C:\Apache24\htdocs\search\index.php on line 12

Deprecated: substr(): Passing null to parameter #1 ($string) of type string is deprecated in C:\Apache24\htdocs\search\index.php on line 12
山崎 智生|信州大学 研究者総覧

山崎 智生 (ヤマザキ トモオ)   

学術研究院(医学系(附属病院))

医学部附属病院 内科(2) 

助教 

学位

  • 医学博士, 信州大学

研究分野

  • ライフサイエンス, 消化器内科学
  • 消化器病学、肝臓学

学歴

  • 2019年, 信州大学大学院医学系研究科
  • 2010年, 鳥取大学医学部

受賞

  • 2023年
    American Association for the Study of Liver Diseases, The Liver Meeting 2023 Poster of Distinction
  • 2019年
    信州大学医学部医学科 研究奨励賞
  • 2018年
    JDDW(日本消化器病週間)2018 若手奨励賞

論文

  • Acute-on-chronic liver failure in primary biliary cholangitis by exacerbation of autoimmune hepatitis features.
    Yoshiaki Kobayashi; Takanobu Iwadare; Masayuki Ida; Chiaki Miyatsu; Yuki Yamashita; Tomoo Yamazaki; Kai Uehara; Takeshi Uehara; Yasuni Nakanuma; Takefumi Kimura
    Clinical journal of gastroenterology, 2025年08月リポジトリ電子ジャーナル
  • Activation of intestinal endogenous retroviruses by alcohol exacerbates liver disease.
    Noemí Cabré; Marcos F Fondevila; Wenchao Wei; Tomoo Yamazaki; Fernanda Raya Tonetti; Alvaro Eguileor; Ricard Garcia-Carbonell; Abraham S Meijnikman; Yukiko Miyamoto; Susan Mayo; Yanhan Wang; Xinlian Zhang; Thorsten Trimbuch; Seija Lehnardt; Lars Eckmann; Derrick E Fouts; Cristina Llorente; Hidekazu Tsukamoto; Peter Stärkel; Bernd Schnabl
    The Journal of clinical investigation, 135(13), 2025年07月リポジトリ電子ジャーナル
  • Thrombospondin 2 as a Predictive Biomarker for HCC in Hepatitis C Patients: A Longitudinal Study Following DAA Therapy.
    Takanobu Iwadare; Takefumi Kimura; Ayumi Sugiura; Taiki Okumura; Shun-Ichi Wakabayashi; Hiroyuki Kobayashi; Yuki Yamashita; Tomoo Yamazaki; Satoru Joshita; Naoki Tanaka; Takeji Umemura
    Journal of viral hepatitis, 32(4), e14025, 2025年04月リポジトリ電子ジャーナル
  • Acute alcohol-associated hepatitis: Latest findings in non-invasive biomarkers and treatment.
    Tomoo Yamazaki; Bernd Schnabl
    Liver international : official journal of the International Association for the Study of the Liver, 45(3), e15608, 2025年03月リポジトリ電子ジャーナル
  • Peroxisome proliferator-activated receptor delta and liver diseases.
    Tomoo Yamazaki; Edward E Cable; Bernd Schnabl
    Hepatology communications, 9(2), 2025年02月リポジトリ電子ジャーナル
  • Serum Autotaxin Levels Predict Liver-Related Events in Patients With Primary Biliary Cholangitis: A Long-Term Multicenter Observational Study.
    Takanobu Iwadare; Takefumi Kimura; Yuki Yamashita; Taiki Okumura; Shun-Ichi Wakabayashi; Hiroyuki Kobayashi; Ayumi Sugiura; Tomoo Yamazaki; Satoshi Shimamoto; Koji Igarashi; Satoru Joshita; Takeji Umemura
    Clinical and translational gastroenterology, 15(12), e00779, 2024年12月リポジトリ電子ジャーナル
  • Serum aryl hydrocarbon receptor activity is associated with survival in patients with alcohol-associated hepatitis.
    Tomoo Yamazaki; Tetsuya Kouno; Cynthia L Hsu; Phillipp Hartmann; Susan Mayo; Xinlian Zhang; Peter Stärkel; Francisco Bosques-Padilla; Elizabeth C Verna; Juan G Abraldes; Robert S Brown Jr; Victor Vargas; Jose Altamirano; Juan Caballería; Debbie L Shawcross; Alexandre Louvet; Michael R Lucey; Philippe Mathurin; Guadalupe Garcia-Tsao; Ramon Bataller; Bernd Schnabl
    Hepatology (Baltimore, Md.), 80(2), 403-417, 2024年08月リポジトリ電子ジャーナル
  • Serum autotaxin is a prognostic indicator of liver-related events in patients with non-alcoholic fatty liver disease.
    Takanobu Iwadare; Takefumi Kimura; Taiki Okumura; Shun-Ichi Wakabayashi; Taro Nakajima; Shohei Kondo; Hiroyuki Kobayashi; Yuki Yamashita; Ayumi Sugiura; Naoyuki Fujimori; Tomoo Yamazaki; Hideo Kunimoto; Satoshi Shimamoto; Koji Igarashi; Satoru Joshita; Naoki Tanaka; Takeji Umemura
    Communications medicine, 4(1), 73-73, 2024年04月リポジトリ電子ジャーナル
  • Thrombospondin 2 is a key determinant of fibrogenesis in non-alcoholic fatty liver disease.
    Takefumi Kimura; Takanobu Iwadare; Shun-Ichi Wakabayashi; Seema Kuldeep; Tomoyuki Nakajima; Tomoo Yamazaki; Daiki Aomura; Hamim Zafar; Mai Iwaya; Satoru Joshita; Takeshi Uehara; Sai P Pydi; Naoki Tanaka; Takeji Umemura
    Liver international : official journal of the International Association for the Study of the Liver, 44(2), 483-496, 2024年02月リポジトリ電子ジャーナル
  • Editorial: Multi-organ linkage pathophysiology and therapy for NAFLD and NASH.
    Takefumi Kimura; Tomoo Yamazaki; Gabriel Rufino Estrela
    Frontiers in endocrinology, 15, 1418066-1418066, 2024年リポジトリ電子ジャーナル
  • HLA-G susceptibility to hepatitis B infection and related hepatocellular carcinoma in the Japanese population.
    Taiki Okumura; Satoru Joshita; Tomoo Yamazaki; Takanobu Iwadare; Shun-Ichi Wakabayashi; Hiroyuki Kobayashi; Yuki Yamashita; Ayumi Sugiura; Takefumi Kimura; Masao Ota; Takeji Umemura
    Human immunology, 84(8), 401-407, 2023年08月リポジトリ電子ジャーナル
  • Symptom-based portopulmonary hypertension screening questionnaire in Japanese patients with chronic liver disease.
    Shun-Ichi Wakabayashi; Satoru Joshita; Kazuhiro Kimura; Hirohiko Motoki; Taiki Okumura; Hiroyuki Kobayashi; Yuki Yamashita; Ayumi Sugiura; Tomoo Yamazaki; Takefumi Kimura; Koichiro Kuwahara; Takeji Umemura
    JGH open : an open access journal of gastroenterology and hepatology, 7(8), 527-536, 2023年08月リポジトリ電子ジャーナル
  • A Diagnostic Impact of Serum Autotaxin Levels in Patients with Bone Marrow Fibrosis.
    Hideyuki Nakazawa; Hiroko Kaiume; Koji Igarashi; Tomoo Yamazaki; Takeji Umemura; Naoko Asano; Takeshi Uehara; Fumihiro Ishida
    Clinical lymphoma, myeloma & leukemia, 23(2), e117-e124, 2023年02月リポジトリ電子ジャーナル
  • Management of Rare Hemorrhage From Collateral Vessels During Gastrostomy Replacement Using Percutaneous Transhepatic Occlusion in Patient With Portal Hypertension.
    Taiki Okumura; Takefumi Kimura; Tomoo Yamazaki; Takayuki Miyazawa; Yoshinori Tsukahara; Masahiro Kurozumi; Yugo Iwaya; Tadanobu Nagaya; Takeji Umemura
    Gastro hep advances, 2(5), 652-655, 2023年リポジトリ電子ジャーナル
  • Circulating thrombospondin 2 levels reflect fibrosis severity and disease activity in HCV-infected patients.
    Takanobu Iwadare; Takefumi Kimura; Naoki Tanaka; Tomoo Yamazaki; Shun-Ichi Wakabayashi; Taiki Okumura; Hiroyuki Kobayashi; Yuki Yamashita; Sai P Pydi; Tomoyuki Nakajima; Mai Iwaya; Ayumi Sugiura; Satoru Joshita; Takeshi Uehara; Takeji Umemura
    Scientific reports, 12(1), 18900-18900, 2022年11月リポジトリ電子ジャーナル
  • Higher Responsiveness for Women, High Transaminase Levels, and Fat Percentage to Pemafibrate Treatment for NAFLD.
    Takanobu Iwadare; Takefumi Kimura; Hideo Kunimoto; Naoki Tanaka; Shun-Ichi Wakabayashi; Tomoo Yamazaki; Taiki Okumura; Hiroyuki Kobayashi; Yuki Yamashita; Ayumi Sugiura; Satoru Joshita; Takeji Umemura
    Biomedicines, 10(11), 2022年11月リポジトリ電子ジャーナル
  • 2-Step PLT16-AST44 method: Simplified liver fibrosis detection system in patients with non-alcoholic fatty liver disease.
    Naoyuki Fujimori; Takefumi Kimura; Naoki Tanaka; Tomoo Yamazaki; Taiki Okumura; Hiroyuki Kobayashi; Shun-Ichi Wakabayashi; Yuki Yamashita; Ayumi Sugiura; Jonathan Pham; Sai P Pydi; Kenji Sano; Satoru Joshita; Takeji Umemura
    Hepatology research : the official journal of the Japan Society of Hepatology, 52(4), 352-363, 2022年04月リポジトリ電子ジャーナル
  • Successful treatment by glecaprevir/pibrentasvir followed by hepatoprotective therapy of acute chronic hepatitis exacerbation caused by daratumumab-based regimen for multiple myeloma: Case report and review of the literature.
    Tomoo Yamazaki; Satoru Joshita; Tetsuya Ichijo; Hiroyuki Kobayashi; Shun-Ichi Wakabayashi; Yuki Yamashita; Ayumi Sugiura; Fumihiro Kawakami; Hideyuki Nakazawa; Takeji Umemura
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 27(12), 1750-1755, 2021年12月リポジトリ電子ジャーナル
  • Association analysis of KIR/HLA genotype with liver cirrhosis, hepatocellular carcinoma, and NUC freedom in chronic hepatitis B patients.
    Satoru Joshita; Masao Ota; Hiroyuki Kobayashi; Shun-Ichi Wakabayashi; Yuki Yamashita; Ayumi Sugiura; Tomoo Yamazaki; Eiji Tanaka; Takeji Umemura
    Scientific reports, 11(1), 21424-21424, 2021年11月リポジトリ電子ジャーナル
  • aMAP score prediction of hepatocellular carcinoma occurrence and incidence-free rate after a sustained virologic response in chronic hepatitis C.
    Yuki Yamashita; Satoru Joshita; Ayumi Sugiura; Tomoo Yamazaki; Hiroyuki Kobayashi; Shun-Ichi Wakabayashi; Yosuke Yamada; Soichiro Shibata; Hideo Kunimoto; Takanobu Iwadare; Makiko Matsumura; Chiharu Miyabayashi; Taiki Okumura; Sachie Ozawa; Yuichi Nozawa; Natsuko Kobayashi; Michiharu Komatsu; Naoyuki Fujimori; Hiromi Saito; Takeji Umemura
    Hepatology research : the official journal of the Japan Society of Hepatology, 51(9), 933-942, 2021年09月リポジトリ電子ジャーナル
  • 9年間の嚢胞性肝病変の経過観察後,肝切除にて診断できた腎細胞癌肝転移の1例
    清水 祐樹, 杉浦 亜弓, 城下 智, 小林 浩幸, 若林 俊一, 山下 裕騎, 山崎 智生, 上原 剛, 清水 明, 副島 雄二, 梅村 武司
    信州医学雑誌, 69(4), 209-215, 2021年08月リポジトリ電子ジャーナル
  • Quantitative and qualitative lipid improvement with chronic hepatitis C virus eradication using direct-acting antivirals.
    Satoru Joshita; Yuki Yamashita; Toru Okamoto; Yoko Usami; Ayumi Sugiura; Tomoo Yamazaki; Akemi Kakino; Masao Ota; Tatsuya Sawamura; Takeji Umemura
    Hepatology research : the official journal of the Japan Society of Hepatology, 51(7), 758-766, 2021年07月リポジトリ電子ジャーナル
  • Investigation of the Effect of KIR-HLA Pairs on Hepatocellular Carcinoma in Hepatitis C Virus Cirrhotic Patients.
    Takeji Umemura; Satoru Joshita; Hiromi Saito; Shun-Ichi Wakabayashi; Hiroyuki Kobayashi; Yuki Yamashita; Ayumi Sugiura; Tomoo Yamazaki; Masao Ota
    Cancers, 13(13), 2021年06月リポジトリ電子ジャーナル
  • An Autopsy Case of Primary Biliary Cholangitis with Histological Submassive Hepatic Necrosis Caused by Acute Hepatitis E Virus Infection.
    Mizuki Koyama; Tomoo Yamazaki; Satoru Joshita; Akihiro Ito; Kazuyuki Ono; Takayuki Watanabe; Yuki Yamashita; Ayumi Sugiura; Mikiko Kobayashi; Yoshinori Sato; Masaharu Takahashi; Hiroaki Okamoto; Takeji Umemura
    Internal medicine (Tokyo, Japan), 60(12), 1863-1870, 2021年06月リポジトリ電子ジャーナル
  • Primary Hepatic Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue in a Patient with Chronic Hepatitis B Virus Infection: Case Report and Summary of the Literature.
    Yuki Yamashita; Satoru Joshita; Hiroyuki Kobayashi; Shun-Ichi Wakabayashi; Ayumi Sugiura; Tomoo Yamazaki; Takeji Umemura
    Medicina (Kaunas, Lithuania), 57(3), 2021年03月リポジトリ電子ジャーナル
  • Serum thrombospondin 2 is a novel predictor for the severity in the patients with NAFLD.
    Takefumi Kimura; Naoki Tanaka; Naoyuki Fujimori; Tomoo Yamazaki; Takahito Katsuyama; Yuichi Iwashita; Jonathan Pham; Satoru Joshita; Sai P Pydi; Takeji Umemura
    Liver international : official journal of the International Association for the Study of the Liver, 41(3), 505-514, 2021年03月リポジトリ電子ジャーナル
  • クローン病の寛解期にサイトメガロウイルス肝炎を発症した1例
    山崎智生; 城下智; 大野和幸; 菅智明; 小林浩幸; 若林俊一; 山下裕騎; 杉浦亜弓; 梅村武司; 梅村武司
    信州医学雑誌, 69(3), 2021年リポジトリ
  • Protocol: Prospective observational study investigating the prevalence and clinical outcome of portopulmonary hypertension in Japanese patients with chronic liver disease.
    Shun-Ichi Wakabayashi; Satoru Joshita; Kazuhiro Kimura; Hirohiko Motoki; Hiroyuki Kobayashi; Yuki Yamashita; Ayumi Sugiura; Tomoo Yamazaki; Koichiro Kuwahara; Takeji Umemura
    PloS one, 16(4), e0249435, 2021年リポジトリ電子ジャーナル
  • Protocol: Prospective observational study aiming for micro-elimination of hepatitis C virus in Nagawa town: The Nagawa Project.
    Hiroyuki Kobayashi; Satoru Joshita; Yuki Akahane; Katsuhiko Matsuzaki; Hiromi Yamada; Daiki Aomura; Nao Joshita; Hajime Midorikawa; Kazuhiro Suyama; Masao Ota; Shun-Ichi Wakabayashi; Yuki Yamashita; Ayumi Sugiura; Tomoo Yamazaki; Hiromichi Misawa; Takeji Umemura
    PloS one, 16(8), e0256711, 2021年リポジトリ電子ジャーナル
  • Clinical impact of normal alanine aminotransferase on direct-acting antiviral outcome in patients with chronic hepatitis C virus infection.
    Satoru Joshita; Ayumi Sugiura; Takeji Umemura; Tomoo Yamazaki; Naoyuki Fujimori; Akihiro Matsumoto; Yoko Usami; Eiji Tanaka
    JGH open : an open access journal of gastroenterology and hepatology, 4(4), 574-581, 2020年08月リポジトリ電子ジャーナル
  • Polymorphism at rs9264942 is associated with HLA-C expression and inflammatory bowel disease in the Japanese.
    Hiroshi Suzuki; Satoru Joshita; Atsuhiro Hirayama; Akihiro Shinji; Kenji Mukawa; Minako Sako; Naoki Yoshimura; Tomoaki Suga; Takeji Umemura; Norihiro Ashihara; Tomoo Yamazaki; Masao Ota
    Scientific reports, 10(1), 12424-12424, 2020年07月リポジトリ電子ジャーナル
  • Clinical utility of FibroScan as a non-invasive diagnostic test for primary biliary cholangitis.
    Satoru Joshita; Yuki Yamashita; Ayumi Sugiura; Takeshi Uehara; Yoko Usami; Tomoo Yamazaki; Naoyuki Fujimori; Akihiro Matsumoto; Eiji Tanaka; Takeji Umemura
    Journal of gastroenterology and hepatology, 35(7), 1208-1214, 2020年07月リポジトリ電子ジャーナル
  • Effectiveness of Glecaprevir/Pibrentasvir for Hepatitis C: Real-World Experience and Clinical Features of Retreatment Cases.
    Ayumi Sugiura; Satoru Joshita; Yuki Yamashita; Tomoo Yamazaki; Naoyuki Fujimori; Takefumi Kimura; Akihiro Matsumoto; Shuichi Wada; Hiromitsu Mori; Soichiro Shibata; Kaname Yoshizawa; Susumu Morita; Kiyoshi Furuta; Atsushi Kamijo; Akihiro Iijima; Satoko Kako; Atsushi Maruyama; Masakazu Kobayashi; Michiharu Komatsu; Makiko Matsumura; Chiharu Miyabayashi; Tetsuya Ichijo; Aki Takeuchi; Yuriko Koike; Yukio Gibo; Toshihisa Tsukadaira; Hiroyuki Inada; Yoshiyuki Nakano; Seiichi Usuda; Kendo Kiyosawa; Eiji Tanaka; Takeji Umemura
    Biomedicines, 8(4), 2020年04月リポジトリ電子ジャーナル
  • Long-term luseogliflozin therapy improves histological activity of non-alcoholic steatohepatitis accompanied by type 2 diabetes mellitus.
    Naoyuki Fujimori; Naoki Tanaka; Takefumi Kimura; Kenji Sano; Akira Horiuchi; Naoyuki Kato; Yoshiyuki Takahashi; Naoya Kuribayashi; Ayumi Sugiura; Tomoo Yamazaki; Satoru Joshita; Takeji Umemura; Akihiro Matsumoto; Eiji Tanaka
    Clinical journal of gastroenterology, 13(1), 83-89, 2020年02月リポジトリ電子ジャーナル
  • 減量導入したレゴラフェニブが奏功し,12カ月以上の長期投与が可能であった多発肝細胞癌・胸椎および副腎転移の1例
    岩垂隆諒; 山崎智生; 城下智; 藤森尚之; 金井圭太; 金井圭太; 山下裕騎; 高橋芳之; 杉浦亜弓; 梅村武司; 梅村武司
    肝臓, 61(8), 2020年リポジトリ
  • Biochemical and plasma lipid responses to pemafibrate in patients with primary biliary cholangitis.
    Satoru Joshita; Takeji Umemura; Yuki Yamashita; Ayumi Sugiura; Tomoo Yamazaki; Naoyuki Fujimori; Akihiro Matsumoto; Eiji Tanaka
    Hepatology research : the official journal of the Japan Society of Hepatology, 49(10), 1236-1243, 2019年10月リポジトリ電子ジャーナル
  • Renal impairment is associated with increased risk of mortality in patients with cirrhosis: A retrospective cohort study.
    Takeji Umemura; Satoru Joshita; Soichiro Shibata; Ayumi Sugiura; Tomoo Yamazaki; Naoyuki Fujimori; Akihiro Matsumoto; Eiji Tanaka
    Medicine, 98(6), e14475, 2019年02月リポジトリ電子ジャーナル
  • Miglitol attenuates non-alcoholic steatohepatitis in diabetic patients.
    Michiharu Komatsu; Naoki Tanaka; Takefumi Kimura; Naoyuki Fujimori; Kenji Sano; Akira Horiuchi; Ayumi Sugiura; Tomoo Yamazaki; Soichiro Shibata; Satoru Joshita; Takeji Umemura; Akihiro Matsumoto; Eiji Tanaka
    Hepatology research : the official journal of the Japan Society of Hepatology, 48(13), 1092-1098, 2018年12月リポジトリ電子ジャーナル
  • Past history of hepatocellular carcinoma is an independent risk factor of treatment failure in patients with chronic hepatitis C virus infection receiving direct-acting antivirals.
    Ayumi Sugiura; Satoru Joshita; Takeji Umemura; Tomoo Yamazaki; Naoyuki Fujimori; Takefumi Kimura; Akihiro Matsumoto; Koji Igarashi; Yoko Usami; Shuichi Wada; Hiromitsu Mori; Soichiro Shibata; Kaname Yoshizawa; Susumu Morita; Kiyoshi Furuta; Atsushi Kamijo; Akihiro Iijima; Satoko Kako; Atsushi Maruyama; Masakazu Kobayashi; Michiharu Komatsu; Makiko Matsumura; Chiharu Miyabayashi; Tetsuya Ichijo; Aki Takeuchi; Yuriko Koike; Yukio Gibo; Toshihisa Tsukadaira; Hiroyuki Inada; Kendo Kiyosawa; Eiji Tanaka
    Journal of viral hepatitis, 25(12), 1462-1471, 2018年12月リポジトリ電子ジャーナル
  • Quantitative analysis of serum chemokines associated with treatment failure of direct-acting antivirals in chronic hepatitis C.
    Takeji Umemura; Tomoo Yamazaki; Satoru Joshita; Ayumi Sugiura; Naoyuki Fujimori; Akihiro Matsumoto; Masao Ota; Eiji Tanaka
    Cytokine, 111, 357-363, 2018年11月リポジトリ電子ジャーナル
  • A cis-eQTL of HLA-DPB1 Affects Susceptibility to Type 1 Autoimmune Hepatitis.
    Tomoo Yamazaki; Takeji Umemura; Satoru Joshita; Kaname Yoshizawa; Eiji Tanaka; Masao Ota
    Scientific reports, 8(1), 11924-11924, 2018年08月リポジトリ電子ジャーナル
  • Serum Autotaxin Is a Useful Disease Progression Marker in Patients with Primary Biliary Cholangitis.
    Satoru Joshita; Takeji Umemura; Yoko Usami; Yuki Yamashita; Gary L Norman; Ayumi Sugiura; Tomoo Yamazaki; Naoyuki Fujimori; Takefumi Kimura; Akihiro Matsumoto; Koji Igarashi; Kaname Yoshizawa; Masao Ota; Eiji Tanaka
    Scientific reports, 8(1), 8159-8159, 2018年05月リポジトリ電子ジャーナル
  • A case of liver abscess co-infected with Desulfovibrio desulfuricans and Escherichia coli and review of the literature.
    Tomoo Yamazaki; Satoru Joshita; Eriko Kasuga; Kazuki Horiuchi; Ayumi Sugiura; Naoyuki Fujimori; Michiharu Komatsu; Takeji Umemura; Akihiro Matsumoto; Eiji Tanaka
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 24(5), 393-397, 2018年05月リポジトリ電子ジャーナル
  • KIR2DL2 combined with HLA-C1 confers risk of hepatitis C virus-related hepatocellular carcinoma in younger patients.
    Hiromi Saito; Takeji Umemura; Satoru Joshita; Tomoo Yamazaki; Naoyuki Fujimori; Takefumi Kimura; Michiharu Komatsu; Akihiro Matsumoto; Eiji Tanaka; Masao Ota
    Oncotarget, 9(28), 19650-19661, 2018年04月リポジトリ電子ジャーナル
  • Mild drinking habit is a risk factor for hepatocarcinogenesis in non-alcoholic fatty liver disease with advanced fibrosis.
    Takefumi Kimura; Naoki Tanaka; Naoyuki Fujimori; Ayumi Sugiura; Tomoo Yamazaki; Satoru Joshita; Michiharu Komatsu; Takeji Umemura; Akihiro Matsumoto; Eiji Tanaka
    World journal of gastroenterology, 24(13), 1440-1450, 2018年04月リポジトリ電子ジャーナル
  • Serum autotaxin levels are correlated with hepatic fibrosis and ballooning in patients with non-alcoholic fatty liver disease.
    Naoyuki Fujimori; Takeji Umemura; Takefumi Kimura; Naoki Tanaka; Ayumi Sugiura; Tomoo Yamazaki; Satoru Joshita; Michiharu Komatsu; Yoko Usami; Kenji Sano; Koji Igarashi; Akihiro Matsumoto; Eiji Tanaka
    World journal of gastroenterology, 24(11), 1239-1249, 2018年03月リポジトリ電子ジャーナル
  • Serum autotaxin is a useful liver fibrosis marker in patients with chronic hepatitis B virus infection.
    Satoru Joshita; Yuki Ichikawa; Takeji Umemura; Yoko Usami; Ayumi Sugiura; Soichiro Shibata; Tomoo Yamazaki; Naoyuki Fujimori; Michiharu Komatsu; Akihiro Matsumoto; Koji Igarashi; Masao Ota; Eiji Tanaka
    Hepatology research : the official journal of the Japan Society of Hepatology, 48(4), 275-285, 2018年03月リポジトリ電子ジャーナル
  • 長期経過加療中の非肝硬変期に肝細胞癌を合併した原発性胆汁性胆管炎の2例
    杉浦 亜弓, 城下 智, 山下 裕騎, 木村 岳史, 山崎 智生, 藤森 尚之, 小松 通治, 松本 晶博, 小林 翔太, 梅村 武司, 田中 榮司
    信州医学雑誌, 66(1), 39-49, 2018年02月リポジトリ電子ジャーナル
  • 多発肝細胞癌・腸骨転移に対し放射線照射・肝動脈化学塞栓術・sorafenib内服を組み合わせた集学的治療を行い長期寛解が得られた1例
    若林俊一; 山崎智生; 城下智; 黒住昌弘; 杉浦亜弓; 藤森尚之; 柴田壮一郎; 市川雪; 森田進; 小松通治; 梅村武司; 松本晶博; 田中榮司
    肝臓, 59(2), 2018年リポジトリ
  • Changes in serum levels of autotaxin with direct-acting antiviral therapy in patients with chronic hepatitis C.
    Tomoo Yamazaki; Satoru Joshita; Takeji Umemura; Yoko Usami; Ayumi Sugiura; Naoyuki Fujimori; Takefumi Kimura; Akihiro Matsumoto; Koji Igarashi; Masao Ota; Eiji Tanaka
    PloS one, 13(4), e0195632, 2018年リポジトリ電子ジャーナル
  • Cimetidine/lactulose therapy ameliorates erythropoietic protoporphyria-related liver injury.
    Naoyuki Fujimori; Michiharu Komatsu; Naoki Tanaka; Mai Iwaya; Hajime Nakano; Ayumi Sugiura; Tomoo Yamazaki; Soichiro Shibata; Yugo Iwaya; Takashi Muraki; Yuki Ichikawa; Takefumi Kimura; Satoru Joshita; Takeji Umemura; Akihiro Matsumoto; Eiji Tanaka
    Clinical journal of gastroenterology, 10(5), 452-458, 2017年10月リポジトリ電子ジャーナル
  • Combination of Killer Immunoglobulin-like Receptor and HLA Genes is Associated with Hepatitis C Virus-Related Hepatocellular Carcinoma
    Umemura, Takeji; Saito, Hiromi; Joshita, Satoru; Yamazaki, Tomoo; Tanaka, Eiji; Ota, Masao;
    Oncotarget, 66, 124A-124A, 2017年10月WebofScience
  • Two cases of non-cirrhotic primary biliary cirrhosis with complicating hepatocellular carcinoma
    Sugiura, Ayumi; Joshita, Satoru; Yamashita, Yuki; Hihara, Yu; Fujimori, Naoyuki; Yamazaki, Tomoo; Maruyama, Yasuhiro; Shibata, Souichiro; Ichikawa, Yuki; Kimura, Takefumi; Ito, Tetsuya; Komatsu, Michiharu; Umemura, Takeji; Matsumoto, Akihiro; Tanaka, Eiji;
    32, 186-186, 2017年09月WebofScience
  • Association of serum autotaxin level with disease stage in Japanese patients with primary biliary cholangitis
    Joshita, Satoru; Umemura, Takeji; Usami, Yoko; Sugiura, Ayumi; Yamazaki, Tomoo; Fujimori, Naoyuki; Komatsu, Michiharu; Matsumoto, Akihiro; Igarashi, Koji; Ota, Masao; Tanaka, Eiji;
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 32, 179-179, 2017年09月WebofScience
  • Association between serum soluble CD14 and IL-8 levels and clinical outcome in primary biliary cholangitis.
    Takeji Umemura; Tomohiro Sekiguchi; Satoru Joshita; Tomoo Yamazaki; Naoyuki Fujimori; Soichiro Shibata; Yuki Ichikawa; Michiharu Komatsu; Akihiro Matsumoto; Zakera Shums; Gary L Norman; Eiji Tanaka; Masao Ota
    Liver international : official journal of the International Association for the Study of the Liver, 37(6), 897-905, 2017年06月リポジトリ電子ジャーナル
  • Association of Serum Autotaxin Levels with Liver Fibrosis in Patients with Chronic Hepatitis C.
    Tomoo Yamazaki; Satoru Joshita; Takeji Umemura; Yoko Usami; Ayumi Sugiura; Naoyuki Fujimori; Soichiro Shibata; Yuki Ichikawa; Michiharu Komatsu; Akihiro Matsumoto; Koji Igarashi; Eiji Tanaka
    Scientific reports, 7, 46705-46705, 2017年04月リポジトリ電子ジャーナル
  • Clinicopathological characteristics of non-B non-C hepatocellular carcinoma without past hepatitis B virus infection.
    Takefumi Kimura; Akira Kobayashi; Naoki Tanaka; Kenji Sano; Michiharu Komatsu; Naoyuki Fujimori; Tomoo Yamazaki; Soichiro Shibata; Yuki Ichikawa; Satoru Joshita; Takeji Umemura; Akihiro Matsumoto; Akira Horiuchi; Hiromitsu Mori; Shuichi Wada; Kendo Kiyosawa; Shin-Ichi Miyagawa; Eiji Tanaka
    Hepatology research : the official journal of the Japan Society of Hepatology, 47(5), 405-418, 2017年04月リポジトリ電子ジャーナル
  • Serum Wisteria floribunda agglutinin-positive human Mac-2 binding protein may predict liver fibrosis and progression to hepatocellular carcinoma in patients with chronic hepatitis B virus infection.
    Yuki Ichikawa; Satoru Joshita; Takeji Umemura; Yugo Shobugawa; Yoko Usami; Soichiro Shibata; Tomoo Yamazaki; Naoyuki Fujimori; Michiharu Komatsu; Akihiro Matsumoto; Eiji Tanaka
    Hepatology research : the official journal of the Japan Society of Hepatology, 47(2), 226-233, 2017年02月リポジトリ電子ジャーナル
  • Massive ascites caused by intra-pancreatic arterioportal fistula: a rare complication of chronic pancreatitis.
    Tomoo Yamazaki; Yasuhide Ochi; Naoki Tanaka; Takayuki Watanabe; Yugo Iwaya; Ayako Seki; Etsuo Hara; Eiji Tanaka; Tomoharu Watanabe; Shun Imai; Osamu Hasebe
    Clinical journal of gastroenterology, 10(1), 73-78, 2017年02月リポジトリ電子ジャーナル
  • Association between endotoxemia and histological features of nonalcoholic fatty liver disease.
    Hiroyuki Kitabatake; Naoki Tanaka; Naoyuki Fujimori; Michiharu Komatsu; Ayaka Okubo; Kyogo Kakegawa; Takefumi Kimura; Ayumi Sugiura; Tomoo Yamazaki; Soichiro Shibata; Yuki Ichikawa; Satoru Joshita; Takeji Umemura; Akihiro Matsumoto; Masayoshi Koinuma; Kenji Sano; Toshifumi Aoyama; Eiji Tanaka
    World journal of gastroenterology, 23(4), 712-722, 2017年01月リポジトリ電子ジャーナル
  • Controlled attenuation parameter is correlated with actual hepatic fat content in patients with non-alcoholic fatty liver disease with none-to-mild obesity and liver fibrosis.
    Naoyuki Fujimori; Naoki Tanaka; Soichiro Shibata; Kenji Sano; Tomoo Yamazaki; Tomohiro Sekiguchi; Hiroyuki Kitabatake; Yuki Ichikawa; Takefumi Kimura; Michiharu Komatsu; Takeji Umemura; Akihiro Matsumoto; Eiji Tanaka
    Hepatology research : the official journal of the Japan Society of Hepatology, 46(10), 1019-27, 2016年09月リポジトリ電子ジャーナル
  • Liver stiffness-spleen size-to-platelet ratio risk score identifies esophageal varices in Japanese patients with chronic hepatitis C.
    Soichiro Shibata; Takeji Umemura; Tomoo Yamazaki; Naoyuki Fujimori; Yuki Ichikawa; Takefumi Kimura; Satoru Joshita; Michiharu Komatsu; Akihiro Matsumoto; Eiji Tanaka
    Hepatology research : the official journal of the Japan Society of Hepatology, 46(9), 884-9, 2016年08月リポジトリ電子ジャーナル
  • A case of simultaneous esophageal squamous cell carcinoma and Barrett's adenocarcinoma.
    Tomoo Yamazaki; Yugo Iwaya; Mai Iwaya; Takayuki Watanabe; Ayako Seki; Yasuhide Ochi; Etsuo Hara; Tomohiro Sekiguchi; Noriko Hosaka; Norikazu Arakura; Eiji Tanaka; Osamu Hasebe
    Clinical journal of gastroenterology, 9(4), 222-7, 2016年08月リポジトリ電子ジャーナル
  • Genetic Association of PTPN22 Polymorphisms with Autoimmune Hepatitis and Primary Biliary Cholangitis in Japan.
    Takeji Umemura; Satoru Joshita; Tomoo Yamazaki; Michiharu Komatsu; Yoshihiko Katsuyama; Kaname Yoshizawa; Eiji Tanaka; Masao Ota
    Scientific reports, 6, 29770-29770, 2016年07月リポジトリ電子ジャーナル
  • Case of Barrett's adenocarcinoma with marked endoscopic morphological changes in Barrett's esophagus over a long follow-up period of 15 years.
    Yugo Iwaya; Tomoo Yamazaki; Takayuki Watanabe; Ayako Seki; Yasuhide Ochi; Etsuo Hara; Norikazu Arakura; Eiji Tanaka; Osamu Hasebe
    Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society, 28(5), 607-10, 2016年07月リポジトリ電子ジャーナル
  • Liver stiffness-spleen size-to-platelet ratio risk score detects esophageal varices in chronic liver disease.
    Soichiro Shibata; Satoru Joshita; Takeji Umemura; Tomoo Yamazaki; Naoyuki Fujimori; Yuki Ichikawa; Michiharu Komatsu; Akihiro Matsumoto; Eiji Tanaka
    SpringerPlus, 5(1), 998-998, 2016年リポジトリ電子ジャーナル

所属学協会

  • 日本消化器内視鏡学会
  • 日本超音波医学会
  • 日本肝臓学会
  • 日本消化器病学会
  • 日本内科学会
  • 日本組織適合性学会

共同研究・競争的資金等の研究課題

  • バクテリオファージによるアルコール性肝炎の精密治療
    海外留学助成リサーチフェローシップ, 上原記念生命科学振興財団
    2022年
  • C型肝炎SVR後発癌に関連する因子の検討
    研究助成金, アッヴィ合同会社
    2021年
  • 消化器病自己免疫性疾患発症と細胞膜上HLA抗原発現量多様性の解析
    科学研究費助成事業, 日本学術振興会, 若手研究
    信州大学
    2020年04月01日 - 2022年03月31日
  • 肝疾患におけるT細胞受容体とB細胞受容体のレパトア解析
    若手医師プロジェクト支援事業, アイバワークス
    2017年
  • C型慢性肝炎患者におけるAutotaxinの肝線維化マーカーとしての有用性の検討
    信州医学振興会
    2016年

その他

  • 日本内科学会総合内科専門医
    2019年12月
  • 日本消化器内視鏡学会専門医
    2019年12月
  • 日本肝臓学会肝臓専門医
    2018年04月
  • 日本消化器病学会消化器病専門医
    2017年01月
  • 日本内科学会認定内科医
    2013年09月